Zhonghua Yu

579 total citations
19 papers, 462 citations indexed

About

Zhonghua Yu is a scholar working on Molecular Biology, Cancer Research and Sensory Systems. According to data from OpenAlex, Zhonghua Yu has authored 19 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Sensory Systems. Recurrent topics in Zhonghua Yu's work include Hearing, Cochlea, Tinnitus, Genetics (5 papers), Hearing Loss and Rehabilitation (4 papers) and MicroRNA in disease regulation (3 papers). Zhonghua Yu is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (5 papers), Hearing Loss and Rehabilitation (4 papers) and MicroRNA in disease regulation (3 papers). Zhonghua Yu collaborates with scholars based in China, Canada and Saudi Arabia. Zhonghua Yu's co-authors include Donghong Yang, Jian Wang, Ying Yu, Zumin Xu, Yufang Zuo, Xiaofen Pan, Gang Peng, Zhixiu Lin, Sha Liu and Shankai Yin and has published in prestigious journals such as Neuroscience, Gene Therapy and International Journal of Oncology.

In The Last Decade

Zhonghua Yu

19 papers receiving 459 citations

Peers

Countries citing papers authored by Zhonghua Yu

Since Specialization

Citations

This map shows the geographic impact of Zhonghua Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghua Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghua Yu more than expected).

Fields of papers citing papers by Zhonghua Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghua Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghua Yu. The network helps show where Zhonghua Yu may publish in the future.

Co-authorship network of co-authors of Zhonghua Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonghua Yu. A scholar is included among the top collaborators of Zhonghua Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonghua Yu. Zhonghua Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma 2020 ·Technology in Cancer Research & Treatment ·Ying Yu, Zhi‐Xiu Lin, Haiwen Li, Haiqing Luo, Donghong Yang, (unknown), (unknown), (unknown), Liu Yang, (unknown), Zhonghua Yu, (unknown)	13
2	Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis 2019 ·Oncology Letters ·Xiaofen Pan, Zhixiu Lin, (unknown), Ying Yu, Donghong Yang, (unknown), (unknown), Sha Liu, Gang Peng, (unknown), Zhonghua Yu	101
3	Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression 2018 ·Journal of Cancer ·Jingjing Li, (unknown), (unknown), Mei Xiang, Jun Yang, Yufang Zuo, Yu Yin, (unknown), (unknown), Haiqing Luo, (unknown), Zhonghua Yu, Zumin Xu	8
4	MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7 2018 ·Technology in Cancer Research & Treatment ·(unknown), (unknown), Qingmei Yang, Yuan Liu, Yan Peng, Hongzhen Zhong, Jun Yang, Huiqing Zhang, Zhonghua Yu, Yufang Zuo, (unknown), Zumin Xu	31
5	Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma 2018 ·Oncology Reports ·Jing Huang, Weiyuan Huang, Mei Liu, Jianping Zhu, (unknown), (unknown), Yan Zhen, Donghong Yang, (unknown), (unknown), Zhonghua Yu	15
6	Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells 2017 ·Oncology Letters ·Mei Xiang, (unknown), Donghong Yang, (unknown), Yufang Zuo, Jingjing Li, (unknown), (unknown), (unknown), Zumin Xu, Zhonghua Yu	12
7	Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc 2017 ·Molecular Medicine Reports ·Yufang Zuo, Dongyan Yang, (unknown), Mei Xiang, (unknown), Jun Yang, Jingjing Li, (unknown), (unknown), Zumin Xu, Zhonghua Yu	20
8	Reduced acoustic startle response and peripheral hearing loss in the5xFADmouse model of Alzheimer's disease 2017 ·Genes Brain & Behavior ·Timothy P. O’Leary, Susan Shin, Emre Fertan, (unknown), Awad M. Almuklass, Roger N. Gunn, Zhonghua Yu, Jian Wang, Richard E. Brown	66
9	Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression 2016 ·International Journal of Oncology ·Xiaofen Pan, Rui Meng, Zhonghua Yu, (unknown), Sha Liu, (unknown), Zhenwei Zou, Gang Wu, Gang Peng	7
10	Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression 2016 ·OncoTargets and Therapy ·(unknown), (unknown), Ying Yu, Jingjing Li, (unknown), (unknown), (unknown), Donghong Yang, Zumin Xu, Zhonghua Yu	24
11	Overexpression of the regulator of G-protein signaling 5 reduces the survival rate and enhances the radiation response of human lung cancer cells 2015 ·Oncology Reports ·Zumin Xu, Yufang Zuo, Jin Wang, Zhonghua Yu, Fang Peng, Yuanyuan Chen, Yong Dong, (unknown), (unknown), (unknown), Yong Bao, Ming Chen	15
12	Noise-induced damage to ribbon synapses without permanent threshold shifts in neonatal mice 2015 ·Neuroscience ·Lijuan Shi, Xiaojing Guo, Pei‐Hong Shen, (unknown), (unknown), Xiaowei Li, Qiang Song, Zhonghua Yu, Shankai Yin, Jian Wang	27
13	Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane 2015 ·Gene Therapy ·(unknown), (unknown), (unknown), Xia Li, (unknown), Zhonghua Yu, Manohar Bance, Shankai Yin, George S. Robertson, Jian Wang	17
14	Antisense oligonucleotides targeting human telomerase mRNA increases the radiosensitivity of nasopharyngeal carcinoma cells 2014 ·Molecular Medicine Reports ·(unknown), Ying Yu, Zumin Xu, (unknown), Dongyan Yang, Mei Xiang, Yufang Zuo, (unknown), (unknown), Zhonghua Yu	12
15	Overexpression of X-Linked Inhibitor of Apoptotic Protein (XIAP) reduces age-related neuronal degeneration in the mouse cochlea 2014 ·Gene Therapy ·Qingwei Ruan, Shan Zeng, (unknown), (unknown), Zhonghua Yu, (unknown), Jieyu He, Manohar Bance, George S. Robertson, Shankai Yin, Jian Wang	7
16	Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway 2014 ·Oncology Reports ·(unknown), Xinggui Chen, Ying Yu, Zhennan Wang, Yufang Zuo, Shuhui Li, Donghong Yang, (unknown), Mei Xiang, Zumin Xu, Zhonghua Yu	28
17	A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma 2014 ·Oncology Reports ·Yufang Zuo, Sihai Liao, Zumin Xu, (unknown), Wenlin Huang, Zhonghua Yu	4
18	Five miRNAs as Novel Diagnostic Biomarker Candidates for Primary Nasopharyngeal Carcinoma 2014 ·Asian Pacific Journal of Cancer Prevention ·Jingfeng Tang, Zhonghua Yu, Tie Liu, Ziying Lin, Yahong Wang, Lawei Yang, Huijuan He, Jun Cao, Haili Huang, Gang Liu	29
19	Overexpression of X-linked inhibitor of apoptosis protein protects against noise-induced hearing loss in mice 2011 ·Gene Therapy ·Jian Wang, (unknown), Zhonghua Yu, Shankai Yin, Manohar Bance, George S. Robertson	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact